- Home
- TRT vs CLNN Comparison
TRT vs CLNN Comparison
Compare TRT & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRT
- CLNN
- Stock Information
- Founded
- TRT 1958
- CLNN 2012
- Country
- TRT United States
- CLNN United States
- Employees
- TRT N/A
- CLNN N/A
- Industry
- TRT Industrial Machinery/Components
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- TRT Technology
- CLNN Health Care
- Exchange
- TRT Nasdaq
- CLNN Nasdaq
- Market Cap
- TRT 22.5M
- CLNN 26.1M
- IPO Year
- TRT N/A
- CLNN N/A
- Fundamental
- Price
- TRT $4.86
- CLNN $2.66
- Analyst Decision
- TRT
- CLNN Strong Buy
- Analyst Count
- TRT 0
- CLNN 5
- Target Price
- TRT N/A
- CLNN $40.00
- AVG Volume (30 Days)
- TRT 5.0K
- CLNN 74.4K
- Earning Date
- TRT 05-13-2025
- CLNN 05-07-2025
- Dividend Yield
- TRT N/A
- CLNN N/A
- EPS Growth
- TRT N/A
- CLNN N/A
- EPS
- TRT 0.00
- CLNN N/A
- Revenue
- TRT $35,548,000.00
- CLNN $350,000.00
- Revenue This Year
- TRT N/A
- CLNN N/A
- Revenue Next Year
- TRT N/A
- CLNN $2,066.67
- P/E Ratio
- TRT $1,112.34
- CLNN N/A
- Revenue Growth
- TRT N/A
- CLNN N/A
- 52 Week Low
- TRT $4.85
- CLNN $2.55
- 52 Week High
- TRT $7.88
- CLNN $9.20
- Technical
- Relative Strength Index (RSI)
- TRT 38.01
- CLNN 37.77
- Support Level
- TRT $5.10
- CLNN $2.91
- Resistance Level
- TRT $5.69
- CLNN $2.90
- Average True Range (ATR)
- TRT 0.21
- CLNN 0.19
- MACD
- TRT 0.02
- CLNN 0.00
- Stochastic Oscillator
- TRT 0.00
- CLNN 18.33
About TRT Trio-Tech International
Trio-Tech International is a provider of third-party semiconductor testing and burn-in services through its laboratories in Southeast Asia. The company operates in four segments namely Manufacturing, Testing services, Distribution, and Real Estate. Its Manufacturing segment manufactures both front-end and back-end semiconductor test equipment and related peripherals. The Testing Services segment renders services to the manufacturer and purchaser of semiconductors and other entities. Its Distribution segment is involved in the distribution of its products. The company's Real Estate segment consists of investment in real estate. Its geographical area of operations includes the United States, Singapore, Malaysia, Thailand, and China. It derives maximum revenue from Testing services Segment.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.